EPO Patents = 5

Forward Citations = 0

Loading Chart...

12 inventors (with patents filed for the assignee):

William Jia (3 out of 3 patents)

Xuexian Bu (2 out of 2 patents)

I-Fang Lee (2 out of 2 patents)

4. Mitchell H Finer (2 out of 6 patents)

5. Luke Evnin (1 out of 4 patents)

6. Christophe Quéva (1 out of 3 patents)

7. Edward Kennedy (1 out of 2 patents)

8. Lorena Lerner (1 out of 3 patents)

9. Dmitry Chouljenko (1 out of 1 patent)

10. Guoyu Liu (1 out of 1 patent)

11. Erica Lee (1 out of 1 patent)

12. Jun Ding (1 out of 1 patent)

13. Zahid Delwar (0 patent)

14. Erica Lee (0 patent)

15. Jun Ding (0 patent)

5 patents: Sort by Forward Citations

1. 12208126 - Oncolytic viral vectors and uses thereof (2025-01-28),

2. 12162919 - Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules (2024-12-10),

3. 11865081 - Oncolytic viral delivery of therapeutic polypeptides (2024-01-09),

4. 11384119 - Compositions and methods for inhibiting CD279 interactions (2022-07-12),

5. 10590169 - Compositions and methods for inhibiting CD279 interactions (2020-03-17),

Company Overview

Virogin Biotech Canada Ltd is a biotechnology company focused on developing innovative oncolytic virus therapies for the treatment of various cancers. Utilizing proprietary virus engineering technologies, Virogin aims to provide effective and safe therapeutic options that enhance the body's immune response to tumors. The company's lead product candidates are being evaluated in clinical trials, with the goal of advancing cancer treatment and improving patient outcomes. Virogin is committed to scientific excellence, patient safety, and bringing novel therapies to market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#22 in

#2,850 in

Richmond, Canada

Virogin Biotech Canada Ltd

Forward Citations = 0

12 inventors:

William Jia (3 out of 3 patents)

Xuexian Bu (2 out of 2 patents)

I-Fang Lee (2 out of 2 patents)

4. Mitchell H Finer (2 out of 6 patents)

5. Luke Evnin (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Virogin Biotech Canada Ltd. Retrieved from https://idiyas.com/company/virogin-biotech-canada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]